Related Experiment Video
Updated: Jan 15, 2026
Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
Prognostic value of coronary CTA-based AI plaque quantification in patients undergoing transcatheter aortic valve
Kifah Hussain1, Kevin Lee2, Senthil S Balasubramanian3
1McGaw Medical Center of Northwestern University, Chicago, IL, USA; Endeavor NorthShore Cardiovascular Institute, Evanston, IL, USA; University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.
Insights
Artificial Intelligence Quantified Coronary Plaque Analysis (AI-QCPA) can predict major adverse cardiac events (MACE) after transcatheter aortic valve implantation (TAVI). Higher plaque volumes identified by AI-QCPA are linked to increased MACE risk within one year post-TAVI.
Area of Science:
- Cardiology
- Medical Imaging
- Artificial Intelligence
Background:
- Coronary artery disease (CAD) is often evaluated during pre-transcatheter aortic valve implantation (TAVI) CT angiography (CTA).
- Quantitative plaque analysis on coronary CTA (CCTA) is now feasible.
- AI-QCPA enables detailed assessment of coronary plaque characteristics.
Purpose of the Study:
- To evaluate the prognostic value of quantitative plaque volumes derived from pre-TAVI CTA using AI-QCPA.
- To determine if AI-QCPA can predict major adverse cardiac events (MACE) within one year post-TAVI.
Main Methods:
- An observational cohort study included 128 patients undergoing CTA for TAVI planning.
- Coronary plaque characteristics were analyzed using AI-QCPA.
- Differences in plaque volumes were compared between patients who did and did not develop MACE within 1 year post-TAVI.
Main Results:
- Patients who developed MACE had significantly higher median total plaque volume (TPV), calcified plaque volume (CPV), non-calcified plaque volume (NCPV), and low-attenuation plaque volume (LAPV).
- The highest quartile of NCPV and LAPV were independently associated with MACE after adjusting for STS score, statin use, and pre-TAVI revascularization.
- Total plaque and all plaque subtypes were independently associated with MACE when adjusted for coronary stenosis.
Conclusions:
- AI-QCPA effectively quantifies coronary plaque in patients undergoing TAVI.
- High coronary plaque volume, particularly NCPV and LAPV, assessed by AI-QCPA, is independently associated with an increased risk of MACE within one year post-TAVI.
Background:
Coronary artery disease can be concomitantly evaluated as part of the pre-transcatheter aortic valve implantation (TAVI) CT angiography (CTA). More recently it has been possible to perform quantitative plaque analysis on coronary CT angiography (CCTA). In this study, we aimed to assess the prognostic value of quantitative plaque volumes using Artificial Intelligence Quantified Coronary Plaque Analysis (AI-QCPA) on pre-TAVI CTA.
Methods:
This observational cohort study included patients who underwent CTA for TAVI planning with concomitant evaluation for coronary atherosclerosis. Studies were performed on a 192-slice dual-source SIEMENS Force CT scanner without administration of pre-medication such as nitroglycerin or beta-blockers. We examined coronary plaque characteristics in TAVI patients with AI-QCPA and assessed differences in plaque volumes between patients who developed major adverse cardiac events (MACE) at one year versus those who did not. MACE was defined as a composite of all-cause mortality, stroke, myocardial infarction, heart failure hospitalization, or unplanned revascularization within 1-year post-TAVI.
Results:
AI-QCPA was performed in 128 patients, with mean age of 80.1 ± 9.6 years (51.6 % male). A total of 24 patients developed MACE at 1 year. Median total plaque volume (TPV), calcified plaque volume (CPV), non-calcified plaque volume (NCPV), and low-attenuation plaque volume (LAPV) were significantly higher in patients who developed MACE. Multivariable regression analysis adjusting for Society of Thoracic Surgeons (STS) score, statin use, and revascularization pre-TAVI, showed that the highest quartile of NCPV (OR 4.56, 95 % CI 1.61-12.89; p = 0.004) and LAPV (OR 3.70, 95 % CI 1.29-10.60; p = 0.015) were independently associated with MACE. When adjusted for coronary stenosis total plaque and all plaque subtypes were independently associated with MACE.
Conclusion:
There is high volume of coronary plaque in patients undergoing TAVI assessed by AI-QCPA which is independently associated with the development of MACE one year post-TAVI.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:28Imaging Studies for Cardiovascular System V: CT